Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Laureate, Tolera Therapeutics Enter Manufacturing Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Laureate, Tolera Therapeutics Enter Manufacturing Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Laureate Pharma has entered into a cGMP contract manufacturing agreement with Tolera Therapeutics, a biotechnology company that develops targeted therapies and safer solutions for immune modulation and related medical needs. Under the agreement, Laureate will produce Tolera’s TOL101 monoclonal antibody under cGMP conditions to be used in clinical trials. Terms of the agreement were not disclosed.
   
“We are pleased to work closely with Tolera to accelerate their antibody therapeutics program to clinic,” said Robert J. Broeze, Ph. D., president and chief executive officer of Laureate. “We are committed to providing Tolera with superior services to help them achieve their manufacturing objectives.”
   
“We are excited to work with Laureate, a company with demonstrated expertise in biopharmaceutical manufacturing. Their capabilities in both clinical and commercial-grade materials can support our aggressive development and commercial plans,” said John J. Puisis, president and chief executive officer of Tolera. “We look forward to our partnership with Laureate in utilizing their specialized experience in the manufacture of monoclonal antibodies.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics